Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Magli

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Genetics|August 19, 2021
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MuscleOlivier Boyer, Gillian Butler-Browne, Hector Chinoy, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana LinfomiMario Levis, Belinda A Campbell, Fabio Matrone, et al.
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
Cells|May 16, 2023
Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem CellsJune Baik, Carolina Ortiz-Cordero, Alessandro Magli, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Genetics|August 19, 2021
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal MuscleOlivier Boyer, Gillian Butler-Browne, Hector Chinoy, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana LinfomiMario Levis, Belinda A Campbell, Fabio Matrone, et al.
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
Cells|May 16, 2023
Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem CellsJune Baik, Carolina Ortiz-Cordero, Alessandro Magli, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Pageof 9